Co-Diagnostics, Inc.
CODX
$0.56
$0.04639.01%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -41.28M | -37.57M | -38.89M | -35.33M | -42.56M |
| Total Depreciation and Amortization | 1.33M | 1.28M | 1.25M | 1.23M | 1.22M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.73M | 11.32M | 9.74M | 7.05M | 15.91M |
| Change in Net Operating Assets | 1.52M | 733.10K | 3.25M | 4.97M | 4.12M |
| Cash from Operations | -25.70M | -24.24M | -24.65M | -22.08M | -21.31M |
| Capital Expenditure | -1.14M | -1.20M | -1.59M | -1.37M | -1.19M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 27.56M | 25.79M | 43.86M | 16.75M | -46.34M |
| Cash from Investing | 26.42M | 24.59M | 42.28M | 15.39M | -47.53M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -159.70K | -326.00K | -881.70K | -1.36M | -2.42M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -159.70K | -326.00K | -881.70K | -1.36M | -2.42M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 557.80K | 28.10K | 16.74M | -8.06M | -71.27M |
